Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hypochondroplasia peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Hypochondroplasia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
1 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 35 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hypochondroplasia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT06455059
ClinicalTrials.gov posted a newer version of NCT06455059, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 12, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07126262
PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- March 31, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06455059
PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.
- PeptideScanner change date
- August 9, 2026
- Cited source date
- January 20, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Vosoritide · 2026-11-12
ClinicalTrials.gov record NCT06455059
Completed at the retained observation.
Open attributed record →Vosoritide · 2026-03-31
ClinicalTrials.gov record NCT07126262
Recruiting at the retained observation.
Open attributed record →